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All patients were nursed in isolation and no secondary cases
occurred. The klebsiella strains showed resistance to cefotaxime and
aztreonam, and up to five further classes of antibiotics. Resistance to
third-generation cephalosporins was successfully transferred to
Escherichia coli J62 from the K pneumoniae strains from the first two
cases, consistent with these ESBLs being plasmid-mediated; and
plasmids of 60 and 70 MD, respectively, were found on agarose gel
electrophoresis.
These three cases illustrate the possible origins of organisms
producing ESBLs-namely, international transfer with the patient,
inter-hospital transfer, and selection of the resistant strain within
a hospital. Nosocomial outbreaks of ESBL-producing
Enterobacteriaceae with multiple resistance2 to a range of antibiotic
classes have occurred in Europe3,4 and the USA. The continued use
of third-generation cephalosporins exerts substantial selection
pressure in favour of ESBL-producing organisms and also for the
evolution of ESBLs. This, together with the introduction of similar
oral cephalosporins, such as ceflxime, into the community, should
prompt laboratory surveillance for such strains. We suggest a
variation of the double-disc synergy test3 on isolates showing
moderate resistance to cefotaxime. Should the use of third-
generation cephalosporins be restricted?7
We thank Dr T. L. Pitt, Central Public Health Laboratory, for serotyping
the isolates, and Prof J. M. T. Hamilton-Miller and Dr S. H. Gillespie for
advice and comments.
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In-vivo monitoring of neuronal loss in
Creutzfeldt-Jakob disease by proton
magnetic resonance spectroscopy
SIR,-The advent of bovine spongiform encephalopathy has
renewed interest in novel approaches to the clinical diagnosis of
spongiform encephalopathies such as Creutzfetdt-Jakob disease
(CJD). We have seen a case of sporadic CJD where the only
magnetic resonance imaging abnormalities were mild cortical
atrophy and hyperintensities in the lentiform nuclei, as noted
previously.’ By contrast, proton magnetic resonance spectroscopy
(MRS) demonstrated significant metabolic alterations in cortical
grey matter and white matter and in striatum. Right frontal lobe
biopsy, done 2 days after these scans, revealed fine vacuolation of
the neuropil (spongiform change) in the deep grey-matter with a
slight loss of neurons and gliosis, consistent with CJD.
After a cold in August, 1990, a 53-year-old woman had difficulty
sleeping and complained of dizziness. When cycling she found it
hard to keep her balance. A neurologist noted trunk and gait ataxia
and a tremor of her right thumb. By October she had become
forgetful, had difficulty expressing herself, and her speech was
Fig 1-Localised proton MR spectra of parietal white-matter.
Upper: Patient with CJD, exhibiting reduction of NAA and PCr/Crand
increase in Ins.
Lower control
Major metabolites include N-acetylaspartate (NAA), glutamate (Glu),
creatine (Cr), and phosphocreatine (PCr), choline-containing
compounds (Cho), and myo-inositol (Ins). Volume of interest 12 ml
slurred. Nocturnal anxiety and paraspasticity ensued and she was
admitted to hospital in November. Her ataxia worsened as did her
memory. Paranoid-hallucinatory states required treatment with
haloperidol for a week. In December a progressive left-sided
spasticity developed. Dysarthria further impeded her speech and
she became demented. CSF analysis revealed oligoclonal banding.
EEGs revealed diffuse slow and a-range complexes with temporo-
occipital sharp wave 6 and 8-complexes. No 1-2 Hz periodic sharp
wave complexes (PSWC) were seen. In February, 1991, the patient
was in a coma and showed spontaneous myoclonus, predominantly
in her right arm. An EEG showed PSWCs, supporting the
diagnosis of CJD. In March localised proton MRS was done with
20 ms echo-time stimulated-echo sequences (2-0 T Siemens
’Magnetom’).3 Measuring times were 6-5 min with 128
accumulations and repetition times of 3 s.
Fig 1 shows the proton MR spectrum of the left parietal
white-matter of the patient, compared with that of a 56-year-old
healthy female control. The N-acetylaspartate (NAA) peak was
reduced (40%), as was the creatine/phosphocreatine ratio (10%);
there was an increase in inositol (30%). Similar findings were
observed contralaterally and in frontal white-matter except for
slightly lower values of choline-containing compounds. Two
volumes of interest in predominantly grey-matter were investigated
in paramedian frontal and parietal locations; only NAA was
diminished (30%) (fig 2). MRS in the hyperintense region of the
striatum showed a fourfold loss of metabolites. The remaining
metabolite pattern exhibited a further reduction of NAA relative to
creatines and cholines.
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Fig 2-Localised proton MR spectra and paramedian grey-
matter.
Upper: Patient with CJD exhibiting reduction of NAA.
Lower. control. Volume of interest 18 ml.
The NAA data, a marker of vital neuronal tissue,’ indicate severe
neuronal loss in CJD. Most notably, MRS in this patient revealed
metabolic alterations in regions of the brain that had appeared
normal on magnetic resonance imaging. Structural preservation in
the presence of gross functional impairment in CJD is often seen
with computerised tomography. Positron emission tomography5,1
reveals hypoperfusion and hypometabolism but proton MRS has
the potential advantage of selectively indicating neuronal damage,
the cell type most severely affected in the spongiform
encephalopathies. This non-invasive investigation could be of use
in the early diagnosis of CJD.
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High frequency of concomitant pancreatitis
in salmonella enteritis
SIR,-Dr Baird-Parker (Nov 17, p 1231) underscores the
increasing incidence of foodborne salmonellosis in many countries
of the western world.l We report some observations that are
relevant to the clinical picture and differential diagnosis of this
diarrhoeal condition.
Stimulated by a case of salmonellosis with severe concomitant
pancreatitis we prospectively followed all culture-proven cases of
salmonella enteritis for symptoms and laboratory signs of
concomitant pancreatitis. Within 18 months we treated 47 patients
with salmonella enteritis (17 men, mean age 45 [range 16-79] years).
16 patients had Salmonella typhimurium and 31 had S enteritidis
infections, 1 patient having both. The frequency of concomitant
pancreatitis as assessed by raised serum amylase and lipase was:
Concomitant pancreatitis No pancreatitis
No 29(62%) 18(38%)
Men/women 8/21 9/9
Mean age (range) 44.8 (18-79) 45-8 (16-71)
Concomitant pancreatitis was found in 7 patients with
S typhimurium and in 22 with S enteritidis (p < 005, Chi-square
test). The course of pancreatitis was usually mild to moderate, with
some pancreatic enlargement, as shown by abdominal sonography,
in about half the patients. Pancreatitis was unrelated to treatment of
salmonellosis either by fluid replacement alone or antibiotics
(mainly ciprofloxacin).
The high frequency of concomitant pancreatitis in salmonella
enteritis in our series is in contrast with other publications. In
gastroenterological textbooks salmonella pancreatitis is not
mentioned2 or is merely listed in tables.3 Only in paediatric
publications has some attention been paid to these forms of
pancreatitis complicating viral or bacterial infections.4 The
pathogenetic mechanisms are unknown as far as we are aware. By
analogy to other infections, a haematogenous attack on parenchymal
pancreatic cells seems probable.
These observations indicate that patients with upper abdominal
pain in salmonella enteritis should be investigated for concomitant
pancreatitis, and in those with hyperamylasaemia and diarrhoea,
salmonellosis should be considered as a possible explanation for this
clinical condition.
Department of Medicine,





1. World Health Organisation. Salmonellosis control: the role of animal and product
hygiene. WHO Tech Rep Ser 1988, no 774.
2. Soergel KH. Acute pancreatitis. In: Sleismger MH, Fordtran JS, eds. Gastrointestinal
disease, 3rd ed. Philadelphia Saunders, 1983: 1462-84.
3. Creutzfeldt W, Lankisch PG. Acute pancreatitis: etiology and pathogenesis. In: Berk
JE, ed. Bockus gastroenterology, 4th ed. Philadelphia: Saunders, 1985. 3971-92.
4. Seifert G. Zur Pathologie der Pankreatitis im Kindesalter. Mschr Kinderheilk 1960;
108: 225-29.
Mega-dose methylprednisolone for chronic
idiopathic thrombocytopenic purpura
SIR,-Dr Balint and colleagues (May 4, p 1106) mention, among
other approaches, conventional prednisolone (1-2 mg/kg daily)
administration for the treatment of idiopathic thrombocytopenic
purpura (ITP).
With colleagues, I have shown that such treatment for 2 weeks is
not effective in ITP; on the contrary it delays spontaneous recovery
in childhood acute ITP.1 Mega-dose oraF or intravenous1.3
methylprednisolone (MDMP; 30 mg/kg daily for 3 days followed
by 20 mg/kg for 4 days; each dose given before 0900 h) has, however,
proved very effective. Platelet counts increased to over 150 000/&micro;l
within 3 days in about two-thirds of patients.1,2 Intravenous
MDMP has also been used successfully in children4-6 and adults7,S
with chronic ITP. We have used oral MDMP (30 mg/kg and 20
mg/kg daily, each for 1 week; every dose before 0900 h) in 10
children with chronic ITP (ie, duration longer than 6 months). 1
child could not be followed. Platelet count increased to over
150 000/&micro;l in 6 patients within 3 days and in 8 by 2 weeks.
